# Study of Dose Adjustment From Levothyroxine to a New Levothyroxine Sodium Test Formulation

> **NCT01916304** · PHASE2 · COMPLETED · sponsor: **Takeda** · enrollment: 101 (actual)

## Conditions studied

- Hypothyroidism

## Interventions

- **DRUG:** Levothyroxine sodium new formulation

## Key facts

- **NCT ID:** NCT01916304
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2015-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01916304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01916304, "Study of Dose Adjustment From Levothyroxine to a New Levothyroxine Sodium Test Formulation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01916304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*